Viewing Study NCT03052205


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2026-01-03 @ 11:07 PM
Study NCT ID: NCT03052205
Status: COMPLETED
Last Update Posted: 2020-02-11
First Post: 2017-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Sponsor: Idera Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module